Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
10
Number of overlapping holdings
26.3%
% of GNOM's 39 holdings also in IDNA
21.7%
% of IDNA's 51 holdings also in GNOM
Overlap by Weight
Sector Drift (GNOM minus IDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in GNOM |
Weight in IDNA |
Overlap | |
|---|---|---|---|---|
 |
BIONTECH SE SPONSORED ADR | 5.0% | 4.1% | 4.1% |
 |
MODERNA, INC. | 2.7% | 3.0% | 2.7% |
|
VIR BIOTECHNOLOGY, INC. | 1.4% | 0.9% | 0.9% |
|
VERVE THERAPEUTICS, INC. | 0.8% | 0.5% | 0.5% |
|
PACIFIC BIOSCIENCES OF CALIF | 0.7% | 0.4% | 0.4% |
Position Highlights (Non-Overlapping Exposures)
GNOM Overweight Relative to IDNA
|
NATERA INC | 6.9% |
|
VERACYTE INC | 4.9% |
|
BIOMARIN PHARMACEUTICAL INC | 4.7% |
|
ALNYLAM PHARMACEUTICALS INC | 4.6% |
|
AGILENT TECHNOLOGIES INC | 4.3% |
|
CRISPR THERAPEUTICS AG | 4.0% |
|
LEGEND BIOTECH CORPORATION SPONSORED | 4.0% |
|
BIO-TECHNE CORPORATION | 3.8% |
|
ARROWHEAD PHARMACEUTICALS, INC. | 3.8% |
|
ULTRAGENYX PHARMACEUTICAL IN | 3.8% |
GNOM Underweight Relative to IDNA
 |
BEIGENE, LTD. | -5.9% |
 |
SANOFI-AVENTIS | -5.5% |
 |
GSK PLC | -5.4% |
 |
ROCHE HOLDING LTD | -5.4% |
|
EXELIXIS INC | -5.3% |
|
ASTRAZENECA PLC | -5.1% |
 |
TAKEDA PHARMACEUTICAL CO LTD | -5.0% |
|
SPRINGWORKS THERAPEUTICS, INC. | -4.8% |
 |
GENMAB A/S | -4.7% |
|
REVOLUTION MEDICINES, INC. | -4.1% |